Pending EO 12866 Regulatory Review

RIN: 0910-AI94	Received Date: 03/04/2026
Title: Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
Agency/Subagency: HHS / FDA	Stage: Proposed Rule
Legal Deadline: Statutory	Economically Significant: No
International Impacts: Yes	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No